期刊文献+

脑胶质瘤化疗进展

暂未订购
导出
摘要 化疗是人脑胶质瘤综合治疗中的重要治疗措施,而局部化疗因能绕过血脑屏障和持续给药而备受关注。笔者对人脑胶质瘤静脉化疗和局部化疗可行性、持续给药的方法以及化疗的药物选择等方面的研究进展进行综述。
出处 《中国民族民间医药》 2010年第24期21-22,共2页 Chinese Journal of Ethnomedicine and Ethnopharmacy
  • 相关文献

参考文献15

  • 1Stewart LA.Chemotherapy in adult high-grade glioma:a systematic review and meta-analysis of individual patient data from 12 randomised trials[J].Lancet,2002,359.
  • 2周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,2007:352-353,387.
  • 3Mutter N,Stupp R.Temozolomide:a milestone in neuro-oncology and beyond[J].Expert Rev Anticancer Ther,2006.
  • 4Stupp Mason WP,Van Dent MJ.Radiotherapy plus concomitant and adjuvant temozolomide for gliobla-stoma[J].N Engl J Med,2005.
  • 5Macdonald DR,Kiebert G.Benefit of emozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse:effect on neurological functioning,performance status,and health related quality of life[J].Cancer Invest,2005.
  • 6沈剑峰,周永庆,詹仁雅,吕世亭,马跃辉,郑杰胜,黄红光,童鹰,万曙,刘凡隆,杨以理.脑胶质瘤同步内放疗和内化疗的临床研究[J].中华神经外科杂志,2002,18(1):44-46. 被引量:15
  • 7MASON JO,FISCHER DH.Intrathecal chemotherapy for recurent central nervous system intraocular lymphoma[J].Ophthalmology,2003,110 (6):1241-1244.
  • 8Langer R.New methods of drug delivery[J].Science,1990.
  • 9周波,黄书岚,刘仁忠.间质内应用BCNU缓释剂治疗恶性脑胶质瘤[J].国外医学(神经病学.神经外科学分册),2003,30(6):580-583. 被引量:3
  • 10Thompson RC,Brem H.Treatmentt of gliomas using polymer-drug delivery[M].From:Berger MS and Wilson CB (eds) W.B.The gilomas.Saunders company,Toronto,1999:555-563.

二级参考文献29

  • 1YANG M B,TAMARGO R J,BREM H.Controlled delivery of 1,3-bis(2-chloroethl)-1-nitrosourea from ethylene-vinyl acetate copolymer.Cancer Res,1989,19:5103-5107.
  • 2Hcohberg FH,Pruitt A.Assumptions in the radiotherapy of glioblastoma.Neurology,1980,30(9):907-911.
  • 3Grossman SA,Reinhard C,Colvin OM,et al.The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers.J Neurosurg,1992,76(4):640-647.
  • 4Brem H,Tamargo R J,Olivi A,et al.Biodegredable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.J Neurosurg,1994,80(2):283-290.
  • 5Sipos EP,Tyler B,Piantadosi S,et al.Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.Cancer Chemother Pharmacol,1995,39(5):383-389.
  • 6Yang MB,Tamargo RJ,Brem H.Controlled delivery of1,3-bis(2-chloroethyl)-lnitrosourea from ethylenevinyl acetate copolymer.Cancer Res,1989,49(18):5103-5107.
  • 7Strasser JF,Fung LK,Eller S,et al.Distribution of 1,3 -bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants.J Pharmacol Exp Ther,1995,275(3):1647-1655.
  • 8Fung LK,Ewend MG,Sills A,et al.Pharmacokinetics of interstitial delivery ofcarmustine,4-hydroperoxycyclophosphamide and paclitaxel from a biodegradable polymer implant in the monkey brain.Cancer Res,1998,58(4):672-684.
  • 9Fleming AB,Saltzman WM,et al.Pharmacokinetics of the carmustine implant.Clin Pharmacokinet,2002,41(6):403-419.
  • 10Vogelhuber W,Spruss T,Bernhardt G.et al.Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts.Int J Pharm.2002,238(1-2):111-121.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部